REV Group, Inc. (REVG)
REV Group, Inc. (REVG) is a manufacturer of specialty vehicles, including buses, ambulances, commercial and recreational vehicles, and adjacent aftermarket parts and services. The company serves various markets such as transportation, emergency response, and recreation, focusing on innovative and durable vehicle solutions.
Dividend History
Investors can expect a dividend payout of $0.06 per share, scheduled to be distributed in 20 days on October 10, 2025
| Pay Date | Amount | Ex-Date | Record Date |
|---|---|---|---|
| October 10, 2025 | $0.06 | 2025-09-26 | 2025-09-26 |
| July 11, 2025 | $0.06 | 2025-06-27 | 2025-06-27 |
| April 11, 2025 | $0.06 | 2025-03-28 | 2025-03-28 |
| January 10, 2025 | $0.06 | 2024-12-26 | 2024-12-26 |
| October 11, 2024 | $0.05 | 2024-09-27 | 2024-09-27 |
Dividends Summary
- REV Group, Inc. has issued 32 dividend payments over the past 8 years
- The most recent dividend was paid 71 days ago, on July 11, 2025
- The highest dividend payed out to investors during this period was $3 per share
- The average dividend paid during this period was $0.14 per share.
Company News
REV Group reported strong Q3 2025 results with $644.9 million in net sales and $64.1 million adjusted EBITDA, driven by Specialty Vehicles segment performance. The company is expanding fire apparatus production capacity by 40% and raising full-year fiscal guidance.
FDH Aero, a global provider of supply chain solutions for the aerospace and defense industry, has appointed Ian Walsh as its new Chief Executive Officer. Walsh succeeds Scott Tucker, who will continue to support FDH in an advisory capacity as its non-executive chairman.
Although the revenue and EPS for REV Group (REVG) give a sense of how its business performed in the quarter ended April 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
U.S. stocks ended higher Monday to start what may be the most pivotal week of 2024 so far.
Shares of Despegar.com, Corp. (NYSE: DESP) rose sharply during Wednesday’s session after the company raised its FY23 financial guidance. The company said it now sees revenue of $690 million to $700 million, versus previous forecast of $670 million to $700 million. Despegar.com shares gained 16.4% to $9.90 on Wednesday. Here are some other stocks moving in today's mid-day session. Gainers Shattuck Labs, Inc. (NASDAQ: STTK) jumped 127.5% to $4.80 after the company announced initial topline dose-expansion data from its ongoing Phase 1A/B clinical trial of SL-172154 in combination with AZA in frontline HR-MDS and TP53m AML patients. ReShape Lifesciences Inc. (NASDAQ: RSLS) shares gained 63.8% to $0.4110 after the company announced it received FDA PMA supplement approval for its next-generation Lap-Band 2.0 FLEX. C4 Therapeutics, Inc. (NASDAQ: CCCC) shares jumped 59% to $3.7199 after the company announced data from the CFT7455 Phase 1 trial in relapsed/refractory multiple myeloma. Following the update, Stifel analyst Bradley Canino upgraded C4 Therapeutics from Hold to Buy and raised the price target from $2 to $12. RiskOn International, Inc. (NASDAQ: ROI) shares gained 38.3% to $0.2016 after declining 9% on Tuesday. Innovative International Acquisition Corp. (NASDAQ: IOAC) shares rose 36% to $11.66. NextPlay Technologies, Inc. (NASDAQ: NXTP) shares gained 26% to $1.1708 after surging 29% on Tuesday. Nephros, Inc. (NASDAQ: NEPH) rose 23% to $3.16. SciSparc Ltd. (NASDAQ: SPRC) gained 21.7% to $5.95 after the company announced results for MitoCareX Bio with its drug discovery platform. Eos Energy Enterprises, ...